An observational study in Low Back Pain, sponsored by Zurich University of Applied Sciences. Completed at 2 sites in Switzerland. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-01-27.
Sponsored by Zurich University of Applied Sciences · Observational
Among 46 studies in Low Back Pain with a site in Switzerland — 8 open to participants now, 8 under way, none of them phase 3. Low Back Pain · Switzerland.
Among the 46 studies in Low Back Pain with a site in Switzerland, this one is the 7th largest by enrollment of the 15 observational ones, is one of 8 that started in 2023, is one of 15 observational ones, and was the 38th registered.
2,922 studies on the registry are indexed under Low Back Pain; 580 are open to participants now.
This study's enrollment of 112 is above the median of 100 across 481 observational studies indexed under Low Back Pain.
Browse Low Back Pain studies →8 of the 46 studies in Low Back Pain with a site in Switzerland are open now, in 1 country. Each count lists the studies.
Of the 333 Low Back Pain studies recruiting now, 92 (28%) set no upper age limit and 211 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.
This study: 18 Years to 75 Years · all sexes · healthy volunteers too.
The full table on the hub →46 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 8 started in 2023.
Median enrollment 102 across the 31 interventional studies, 105 across the 15 observational. Of the 35 that completed or were terminated, 2 (6%) have results posted.
4 of 46 have an industry lead sponsor. The 10 most frequent:
Zurich University of Applied Sciences is the lead sponsor of 23 studies on the registry; none are open to participants now.
Zurich University of Applied Sciences has 2 studies filed under Low Back Pain — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 46 studies in Low Back Pain with a site in Switzerland, from their registry updates:
This research aims to assess the cross-cultural validity and reliability of the German version of the Back-PAQ (Back-PAQ_G) within the German-speaking Swiss population.
The target population for this study includes individuals with and without back pain and primary care healthcare professionals. This includes physicians, physiotherapists, and nurses. The participants will be asked to fill out the Back-PAQ_G and similiar questionnaires online.
The target population for this study includes individuals with and without back pain and primary care healthcare professionals. This includes physicians, physiotherapists, and nurses.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Back Pain and Attitudes Questionnaire
The Back-PAQ_G contains 34 statements about the lower back and back pain that have to be rated as "true", "uncertain" or "false". Scores range from 34 to 170. The higher the score, the more unhelpful attitudes toward the back and back pain are present. Participants will receive the German version of the Back-PAQ (Back-PAQ_G).
Time frame: baseline
Tampa Scale of Kinesiophobia
The TSK examines fear of movement and injury. The TSK applies to individuals with and without pain. The scores range from 11 to 44. A higher score on the completed questionnaire implies high kinesiophobia and an existing somatic focus. The participants of the study receive the German version of TSK-GV with eleven questions.
Time frame: baseline
Fear Avoidance Belief Questionnaire
The FABQ examines fear avoidance attitudes about the effect of work and activity on lower back pain. The questionnaire applies to individuals with low back pain. The maximum score is 96. A high score indicates a strong fear-avoidance posture for low back pain. Participants with current low back pain receive the validated German version of the FABQ with 16 questions.
Time frame: baseline
Plan to share: Undecided
Ran from Oct 2023 to primary completion in May 2024, 6 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Zurich University of Applied Sciences